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Restless legs syndrome is also known as Ekbom's yndrome, following his description i  1944, although the earliest 
known description dates from 1685 (Willis). It is a fairly common complaint which is not widely recognised by the 
medical profession. It gives the sufferer an unpleasant sensation i the legs at rest, causing an irresistible desire to move, 
which alleviates the discomfort. 
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Incidence 
Restless legs syndrome (RLS) affects 5% of the popu- 
lation. Both males and females are affected, but those 
with severe symptoms are usually female. ~'2 The syn- 
drome can occur at any age, but is more common in 
the elderly, s Certain groups who have a higher in- 
cidence have been identified, and these include 
patients presenting to surgical outpatient clinics, and 
particularly those presenting with varicose veins (15- 
22%4'5), pregnant women 6and dialysis patients. 7 Some 
families how a familial tendency, ~ with an autosomal 
dominant pattern of transmission. RLS has been as- 
sociated with a large number of conditions, including 
anaemia, deficiencies of iron, folic acid and mag- 
nesium, uraemia, rheumatoid arthritis, amyloidosis, 
carcinoma, stress and depression, chronic lung disease, 
caffeine and a number of drugs. 1'7-1° RLS is a common 
cause of insomnia. ~
Aetiology and Pathogenesis 
Despite the vast number of conditions reported to be 
associated with RLS, there are no proven aetiological 
factors. Metcalfe t al. ~1 presented two possible theories 
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Table 1. Diagnostic riteria for Restless Legs Syndrome. 
Sensations occur only at rest 
Worse during evening and early night 
Cause irresistible urge to move legs 
Felt deep inside legs, not in skin 
to explain the symptoms: the vascular and the neuro- 
pathic. The vascular theory postulates an impairment 
in the local circulation, causing ischaemia or a build- 
up of toxic metabolites. The associations with varicose 
veins and anaemia re thought to support his theory, 
as is the relief which may be obtained by movement, 
fever and vasodilators, which all increase local blood 
flOW. 
The neuropathic theory suggests a minor ab- 
normality in the central nervous system, possibly in 
the EEG 3's or in the dopaminergic or endogenous 
opioid pathways. 12'~3 Other movement disorders, such 
as Parkinson's disease and Tourette's syndrome, may 
be caused by an imbalance in central neuro- 
transmitters, and dopaminergic and opioid drugs can 
be effective therapy for restless legs. The relief of 
symptoms produced by movement or rubbing may be 
due to the afferent sensory input effect. In view of the 
association with varicose veins, Kanter 5has suggested 
that microcirculatory changes in the small superficial 
veins may cause restless sensations by stimulation 
of afferent nerve fibres. EMG and nerve conduction 
studies, nerve and muscle biopsies have not shown 
any consistent abnormality. 
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Table 2. Treatment regimens for Restless Legs Syndrome. 
Reassurance 
Varicose veins - sclerotherapy or surgery 
Drugs 
Benzodiazepines 
e.g. Clonazepam i mg nocte 
Dopaminergic agents 
e.g. Madopar (benserazide ÷ levodopa) 62.5-250 mg nocte 
Others 
e.g. Quinidine, Chlorpromazine, Sodium valproate, Paroven 
Clinical Features 
There is an unpleasant sensation felt deep inside the 
legs, often described as a "creeping" or "crawling" 
sensation. This occurs at rest, usually in the evening 
and night, and is worse after a tiring day. It causes an 
irresistible urge to move the legs, often by getting up 
and walking around, which relieves the sensation but 
may seriously disturb the sleep pattern of the sufferer. 
Symptoms are usually bilateral, and felt in the calves 
(Table 1), but if severe may involve the feet, thighs 
and even the arms. Many sufferers also have periodic 
leg movements during sleep. 14 
RLS is a chronic condition, with alternating periods 
of exacerbation and remission, but no obvious factors 
to explain the variation. The majority of sufferers 
have only mild symptoms, but those who are severely 
affected may develop symptoms whenever at rest, 
making them unable to sit still for any length of time, 
with adverse ffects on their work and social activities, 
as well as sleep disturbances, which may result in 
anxiety and depression. 
Treatment 
There is no really effective treatment for RLS. In mild 
cases, no treatment is required, and simple measures 
such as massage and movement may help. Re- 
assurance and advice to decrease tiring activity is 
often beneficial. For those with varicose veins, injection 
sclerotherapy has been shown to be very effective in 
alleviating restlessness in the short-term, and has the 
advantage of avoiding long-term medication. 5 
Many drugs have been tried, none with consistent 
success. Ekbom 1 noted that "a certain medicine seems 
to be helpful for a time but is subsequently ineffective". 
Montplaisir et al. 14 reviewed the three main groups of 
drugs used. These are benzodiazepines, in particular 
clonazepam, which is the initial treatment of choice, 
especially in the young; opioids, which are effective 
in some patients, but carry the risk of abuse and 
addiction; and dopaminergic agents uch as levodopa, 
bromocriptine and selegiline, which have the side 
effects of an increase in symptoms during the daytime 
following an evening dose and insomnia, due to an 
alerting effect. 
A number of other drugs have been used, including 
quinine, vitamins, iron 1 and folic acid although no 
controlled studies have shown them to be effective 
(Table 2). Vasodilators, 1 clonidine 15 and carbamaz- 
epine 16 have also been tried. The rutoside Paroven has 
a therapeutic effect in restless legs associated with 
varicose veins, 17 which may be due to an increased 
oxygen level in the blood, or to decreased interstitial 
fluid pooling as a result of reduced capillary per- 
meability. I1,~8 
Diagnosis 
Diagnosis is based on the typical history, as there are 
no consistent findings on examination or investigation. 
Ekbom 1 stated that the following criteria are required 
for diagnosis: the sensations appear only at rest, are 
felt deep inside the legs, not in the skin, occur most 
often in the evening and early part of the night, and 
produce an irresistible need to keep the legs moving. 
In a patient presenting with restless legs, a blood test 
to exclude iron-deficiency anaemia and uraemia is 
worthwhile, in view of the association with these 
conditions. It is important to exclude any other cause 
of the symptoms, especially in the case of sudden 
onset of severe symptoms, when a psychiatric disorder, 
a neurological disorder such as multiple sclerosis, or 
a drug reaction may be responsible. 
Conclusion 
Restless legs syndrome is often ignored by the medical 
profession, probably because of the absence of both a 
clear explanation for the symptoms, and an effective 
treatment. For many, who have only minor symptoms, 
recognition of the syndrome and reassurance may 
considerably alleviate their suffering, but can only be 
given if the doctor is aware of the syndrome. We 
therefore suggest that it is important to increase aware- 
ness of this condition among doctors. 
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